January 2021 Volume 17, Issue 1
Volume 17, Issue 1 | January 2021
December 2020/January 2021
In this Issue
Preclinical
Deep learning for drug design
Metabolite Translator assesses safety of novel compoundsPassage makes progress against rare lysosomal storage disease
Preclinical data show injection of optimized AAV vector may correct gangliosidosisGood news for PolyPEPI-SCoV-2
PepTC reports positive preclinical results for peptide vaccine
Exosomes to the rescue in cancer
Codiak demonstrates potential of engineered exosomes to stimulate targeted, antitumor immunityTools & Technology
Machine learning improves tandem MS
Purdue researchers apply machine learning concepts to create a new mass spec methodReaction rules
Retrosynthesis tool automates molecule makingQ&A: A jump to the next step in sequencing
Jumpcode details how its CRISPRclean tech unites NGS and CRISPR/Cas editingClinical Trials
Good news to wake up to
Jazz reports promising results for Xywav in adults with rare sleep disorderPutting RWD and NHD up against placebo
Results from cTAP indicate both could augment or replace placebo controls in DMD clinical trialsPsoriasis progress
EDP1815 Phase 1b data shared at EADV VirtualAtossa shares Phase 1 results for AT-301
Preliminary results show safety and tolerability of AT-301 nasal spray for COVID-19Diagnostics
Heavy lifting with HULLK
APIS, University of Virginia hope to leverage HULLK lncRNA as a prostate cancer biomarker
Tracing cancer with tattoo ink
USC researchers say tattoo inks and food dyes could help improve cancer detectionFunctional MRI: The next tool for mental health?
Researchers develop an algorithm for predicting medication response in mental health patientsFive minutes, one answer
A breath test to rapidly diagnose COVID-19 infection may be on the way from imecDiscovery
Bugs making drugs: Harnessing bacteria to treat disease
Bacteria engineered to produce therapeutics fill a niche for patients with unmet medical needs.Choosing CRISPR in the fight against SARS-CoV-2
Study demonstrates how changes in human genes can reduce SARS-CoV-2 infectionBraking macrophages
Molecule mimics naturally occurring protein to prevent overreactionGetting answers on GABAergic neurons
UTSA researchers find breakthrough discovery on brain cortex functionalityArming the industry to fight AMR
The AMR Action Fund seeks to support antibiotic candidates in massive industry-philanthropic allianceSpecial Reports
Beyond Vaccines
Researchers are seeking antivirals to protect the unprotectedFeature
SLAS prepares for digital event to “Ignite 2021 with a spark”
Get a look at what the Society for Laboratory Automation and Screening’s virtual annual meeting has to offerCommentary
Goodbye DDNews; hello DDN
With our first issue of 2021, we have lots of great changes to bring youThe easy way in
Wide adoption and regimen compliance are two reasons for easier administration, whether with COVID or schizophreniaEditor's Focus
